BetterLife Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:NPAU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Mar 25Buy€291Stephen SanghaIndividual5,000€0.058
26 Mar 25Buy€2,763Stephen SanghaIndividual50,000€0.055
11 Mar 25Buy€3,065Stephen SanghaIndividual57,000€0.054
27 Feb 25Buy€1,132Stephen SanghaIndividual17,000€0.067
18 Feb 25Buy€2,627Stephen SanghaIndividual39,000€0.067
07 Feb 25Buy€2,904Stephen SanghaIndividual43,000€0.068
06 Feb 25Buy€7,411Stephen SanghaIndividual100,000€0.074
20 Jan 25Buy€10,396Stephen SanghaIndividual129,000€0.081
14 Jan 25Buy€15,561Stephen SanghaIndividual200,000€0.078
13 Jan 25Buy€8,664Stephen SanghaIndividual110,756€0.078
10 Jan 25Buy€1,880Stephen SanghaIndividual24,152€0.078
18 Dec 24Buy€909Stephen SanghaIndividual13,000€0.07
18 Dec 24Buy€2,588Stephen SanghaIndividual37,000€0.07
17 Dec 24Buy€3,680Stephen SanghaIndividual52,700€0.07
17 Dec 24Buy€3,492Stephen SanghaIndividual50,000€0.07
13 Dec 24Buy€1,399Stephen SanghaIndividual19,000€0.074
12 Dec 24Buy€1,932Stephen SanghaIndividual25,000€0.077
06 Dec 24Buy€6,472Stephen SanghaIndividual87,900€0.074
08 Aug 24Buy€9,276Stephen SanghaIndividual107,000€0.087
14 Jun 24Buy€34,003Ahmad DoroudianIndividual500,000€0.068

Insider Trading Volume

Insider Buying: NPAU insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NPAU?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders46,973,19535.9%
General Public83,784,85164.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 35.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
Stephen Sangha
20,750,756€1.5m3.88%no data
11.7%
Ahmad Doroudian
15,263,313€1.1m25.9%no data
5.27%
Hooshmand Sheshbaradaran
6,892,653€491.5k397%no data
1.25%
Moira Ong
1,637,825€116.8k157%no data
0.75%
Hamid Doroudian
987,148€70.4k0%no data
0.65%
Robert Metcalfe
855,000€61.0k-25.3%no data
0.44%
Wolfgang Renz
581,500€41.5k1,490%no data
0.0038%
Ralph Pullen
5,000€356.266.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/25 12:30
End of Day Share Price 2025/05/23 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BetterLife Pharma Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.